Neonc Technologies (NASDAQ:NTHI) Now Covered by Maxim Group

Investment analysts at Maxim Group started coverage on shares of Neonc Technologies (NASDAQ:NTHIGet Free Report) in a research note issued to investors on Monday. The firm set a “buy” rating and a $20.00 price target on the stock. Maxim Group’s price objective indicates a potential upside of 263.64% from the company’s current price.

NTHI has been the subject of several other reports. BTIG Research began coverage on Neonc Technologies in a research report on Friday, April 24th. They issued a “buy” rating and a $15.00 target price for the company. Weiss Ratings restated a “sell (e+)” rating on shares of Neonc Technologies in a research note on Friday, March 27th. Two investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Neonc Technologies presently has a consensus rating of “Hold” and a consensus target price of $17.50.

Check Out Our Latest Research Report on NTHI

Neonc Technologies Price Performance

NTHI stock opened at $5.50 on Monday. Neonc Technologies has a twelve month low of $3.20 and a twelve month high of $12.99. The business’s 50-day simple moving average is $6.42 and its 200 day simple moving average is $8.18.

Neonc Technologies (NASDAQ:NTHIGet Free Report) last posted its quarterly earnings results on Monday, May 18th. The company reported ($0.38) EPS for the quarter, missing the consensus estimate of ($0.22) by ($0.16).

Insider Buying and Selling

In related news, President Amir F. Heshmatpour purchased 10,000 shares of the stock in a transaction on Friday, May 1st. The shares were purchased at an average cost of $4.16 per share, for a total transaction of $41,600.00. Following the completion of the transaction, the president directly owned 3,072,000 shares of the company’s stock, valued at approximately $12,779,520. The trade was a 0.33% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Over the last quarter, insiders acquired 80,700 shares of company stock valued at $423,590.

Institutional Investors Weigh In On Neonc Technologies

Institutional investors and hedge funds have recently made changes to their positions in the company. Bank of America Corp DE grew its holdings in shares of Neonc Technologies by 1.0% in the 3rd quarter. Bank of America Corp DE now owns 226,486 shares of the company’s stock worth $2,056,000 after purchasing an additional 2,207 shares during the last quarter. Westmount Partners LLC boosted its position in Neonc Technologies by 7.7% in the fourth quarter. Westmount Partners LLC now owns 43,320 shares of the company’s stock valued at $358,000 after buying an additional 3,112 shares in the last quarter. State Street Corp grew its stake in Neonc Technologies by 9.9% during the fourth quarter. State Street Corp now owns 43,170 shares of the company’s stock worth $357,000 after buying an additional 3,900 shares during the last quarter. Barclays PLC grew its stake in Neonc Technologies by 5,314.8% during the fourth quarter. Barclays PLC now owns 9,151 shares of the company’s stock worth $76,000 after buying an additional 8,982 shares during the last quarter. Finally, Foundations Investment Advisors LLC acquired a new stake in shares of Neonc Technologies during the third quarter worth approximately $100,000.

Neonc Technologies Company Profile

(Get Free Report)

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.

Featured Articles

Receive News & Ratings for Neonc Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neonc Technologies and related companies with MarketBeat.com's FREE daily email newsletter.